TIROSINT | Licensing, EU CTD Dossiers, Formulation Listed Suppliers | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

TIROSINT
Listed Dossiers

PharmaCompass Sponsored Ads

Contact Supplier

Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Contact Supplier

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

Contact Supplier

TIROSINT

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 15 USDMF, 12 CEP/COS, 2 JDMF, 4 EU WC, 5 KDMF, 18 NDC API, 16 Listed Suppliers, $ API Reference Price

45 API Suppliers
15 USDMF
12 CEP/COS
2 JDMF
4 EU WC
5 KDMF
18 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

31 Drugs in Development

31 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

895 FDF Dossiers, 267 FDA Orange Book, 473 Europe, 41 Canada, 37 Australia, 33 South Africa, 44 Listed Dossiers

895 FDF Dossiers
267 FDA Orange Book
473 Europe
41 Canada
37 Australia
33 South Africa
44 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.0125MG;0.0031MG, TABLET;ORAL - 0.025MG;0.0063MG, TABLET;ORAL - 0.05MG;0.0125MG, TABLET;ORAL - 0.15MG;0.0375MG, TABLET;ORAL - 0.1MG;0.025MG, POWDER;INTRAVENOUS - 100MCG/VIAL, POWDER;INTRAVENOUS - 200MCG/VIAL, POWDER;INTRAVENOUS - 500MCG/VIAL, TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium, CAPSULE;ORAL - 0.013MG, CAPSULE;ORAL - 0.025MG, CAPSULE;ORAL - 0.0375MG, CAPSULE;ORAL - 0.044MG, CAPSULE;ORAL - 0.05MG, CAPSULE;ORAL - 0.0625MG, CAPSULE;ORAL - 0.075MG, CAPSULE;ORAL - 0.088MG, CAPSULE;ORAL - 0.112MG, CAPSULE;ORAL - 0.125MG, CAPSULE;ORAL - 0.137MG, CAPSULE;ORAL - 0.15MG, CAPSULE;ORAL - 0.175MG, CAPSULE;ORAL - 0.1MG, CAPSULE;ORAL - 0.2MG

TABLET;ORAL - 0.0125MG;0.0031MG
TABLET;ORAL - 0.025MG;0.0063MG
TABLET;ORAL - 0.05MG;0.0125MG
TABLET;ORAL - 0.15MG;0.0375MG
TABLET;ORAL - 0.1MG;0.025MG
POWDER;INTRAVENOUS - 100MCG/VIAL
POWDER;INTRAVENOUS - 200MCG/VIAL
POWDER;INTRAVENOUS - 500MCG/VIAL
TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL - 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
CAPSULE;ORAL - 0.013MG
CAPSULE;ORAL - 0.025MG
CAPSULE;ORAL - 0.0375MG
CAPSULE;ORAL - 0.044MG
CAPSULE;ORAL - 0.05MG
CAPSULE;ORAL - 0.0625MG
CAPSULE;ORAL - 0.075MG
CAPSULE;ORAL - 0.088MG
CAPSULE;ORAL - 0.112MG
CAPSULE;ORAL - 0.125MG
CAPSULE;ORAL - 0.137MG
CAPSULE;ORAL - 0.15MG
CAPSULE;ORAL - 0.175MG
CAPSULE;ORAL - 0.1MG
CAPSULE;ORAL - 0.2MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 21 SPI Pharma, 1 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 8 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 2 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 16 BASF, 1 CD Formulation, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 1 JJ Chemicals, 20 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 3 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 31 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 5 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 39 Coating Systems & Additives, 34 Direct Compression, 29 Disintegrants & Superdisintegrants, 29 Granulation, 26 Parenteral, 24 Taste Masking, 24 Thickeners and Stabilizers, 20 Chewable & Orodispersible Aids, 19 Controlled & Modified Release, 19 Lubricants & Glidants, 15 Solubilizers, 13 Co-Processed Excipients, 9 Empty Capsules, 8 Film Formers & Plasticizers, 7 API Stability Enhancers, 7 Topical, 6 Emulsifying Agents, 4 Vegetarian Capsules, 3 Rheology Modifiers, 2 Coloring Agents, 1 Surfactant & Foaming Agents

72 Fillers, Diluents & Binders
39 Coating Systems & Additives
34 Direct Compression
29 Disintegrants & Superdisintegrants
29 Granulation
26 Parenteral
24 Taste Masking
24 Thickeners and Stabilizers
20 Chewable & Orodispersible Aids
19 Controlled & Modified Release
19 Lubricants & Glidants
15 Solubilizers
13 Co-Processed Excipients
9 Empty Capsules
8 Film Formers & Plasticizers
7 API Stability Enhancers
7 Topical
6 Emulsifying Agents
4 Vegetarian Capsules
3 Rheology Modifiers
2 Coloring Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 95 News #PharmaBuzz

2 Data Compilation #PharmaFlow
95 News #PharmaBuzz

GLOBAL SALES INFORMATION

30 US Medicaid Prescriptions, 103 Regulatory FDF Prices, 8 Annual Reports

30 US Medicaid Prescriptions
103 Regulatory FDF Prices
8 Annual Reports

MARKET PLACE

31 APIs, 14 FDF Dossiers

31 APIs
14 FDF Dossiers

PATENTS & EXCLUSIVITIES

101 US Patents

101 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 7 Others

3 EDQM
2 USP
7 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 5,463 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

44 All

01 12Ascent Innovative Medicines

02 3Biological E

03 12Intas Pharmaceuticals

04 4KMS Health Center Pvt. Ltd

05 5Madras Pharmaceuticals

06 2Swasthya Healthcare

07 3Wockhardt Limited

08 3World Medicine

filter Active Ingredients Reset all filters

44 All

01 2Levothyroxine

02 42Levothyroxine Sodium

filter Dosage Reset all filters

44 All

01 3Oral Solution

02 1Softgelatin Capsule

03 3TABLETS

04 34Tablet

05 3Vial

filter Dosage Strength Reset all filters

44 All

01 8100MCG

02 1100MCG/5ML

03 2112MCG

04 112.5MCG

05 2125MCG

06 2137MCG

07 2150MCG

08 2175MCG

09 3200MCG

10 625MCG

11 125MCG/5ML

12 2300MCG

13 1500MCG

14 550MCG

15 150MCG/5ML

16 375MCG

17 288MCG

filter Country Reset all filters

44 All

01 41India

02 3Turkey

List of Suppliers

Product Main Page

01

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Levothyroxine Sodium

Brand Name :

Dosage Form : Tablet

Dosage Strength : 25MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

01

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Levothyroxine Sodium

Dosage : Tablet

Dosage Strength : 25MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Levothyroxine Sodium

Brand Name :

Dosage Form : Tablet

Dosage Strength : 50MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Levothyroxine Sodium

Dosage : Tablet

Dosage Strength : 50MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Levothyroxine Sodium

Brand Name :

Dosage Form : Tablet

Dosage Strength : 75MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Levothyroxine Sodium

Dosage : Tablet

Dosage Strength : 75MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Levothyroxine Sodium

Brand Name :

Dosage Form : Tablet

Dosage Strength : 88MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Levothyroxine Sodium

Dosage : Tablet

Dosage Strength : 88MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Levothyroxine Sodium

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Levothyroxine Sodium

Dosage : Tablet

Dosage Strength : 100MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Levothyroxine Sodium

Brand Name :

Dosage Form : Tablet

Dosage Strength : 112MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Levothyroxine Sodium

Dosage : Tablet

Dosage Strength : 112MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Levothyroxine Sodium

Brand Name :

Dosage Form : Tablet

Dosage Strength : 125MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Levothyroxine Sodium

Dosage : Tablet

Dosage Strength : 125MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Levothyroxine Sodium

Brand Name :

Dosage Form : Tablet

Dosage Strength : 137MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Levothyroxine Sodium

Dosage : Tablet

Dosage Strength : 137MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Levothyroxine Sodium

Brand Name :

Dosage Form : Tablet

Dosage Strength : 150MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Levothyroxine Sodium

Dosage : Tablet

Dosage Strength : 150MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Levothyroxine Sodium

Brand Name :

Dosage Form : Tablet

Dosage Strength : 175MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Ascent Innovative Medicines

PCHi

Not Confirmed

Ascent Innovative Medicines

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Levothyroxine Sodium

Dosage : Tablet

Dosage Strength : 175MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.